Clinical characteristics and preventable acute care spending among a high cost inpatient population by Paul E. Ronksley et al.
RESEARCH ARTICLE Open Access
Clinical characteristics and preventable
acute care spending among a high cost
inpatient population
Paul E. Ronksley1*, Daniel M. Kobewka2,3, Jennifer A. McKay3, Deanna M. Rothwell4, Sunita Mulpuru2,3
and Alan J. Forster2,4,5
Abstract
Background: A small proportion of patients account for the majority of health care spending. The objectives of this
study were to explore the clinical characteristics, patterns of health care use, and the proportion of acute care spending
deemed potentially preventable among high cost inpatients within a Canadian acute-care hospital.
Methods: We identified all individuals within the Ottawa Hospital with one or more inpatient hospitalization
between April 1, 2010 and March 31, 2011. Clinical characteristics and frequency of hospital encounters were
captured in the information systems of the Ottawa Hospital Data Warehouse. Direct inpatient costs for each
encounter were summed using case costing information and those in the upper first and fifth percentiles of the
cumulative direct cost distribution were defined as extremely high cost and high cost respectively. We quantified
preventable acute care spending as hospitalizations for ambulatory care sensitive conditions (ACSC) and spending
attributable to difficulty discharging patients as measured by alternate level of care (ALC) status.
Results: During the study period, 36,892 patients had 44,066 hospitalizations. High cost patients (n = 1,844) accounted
for 38 % of total inpatient spending ($122 million) and were older, more likely to be male, and had higher levels
of co-morbidity compared to non-high cost patients. In over half of the high cost cohort (54 %), costs were
accumulated from a single hospitalization. The majority of costs were related to nursing care and intensive care
unit spending. High cost patients were more likely to have an encounter deemed to be ambulatory care sensitive
compared to non-high cost inpatients (6.0 versus 2.8 %, p < 0.001). A greater proportion of inpatient spending
was attributable to ALC days for high cost versus non-high cost patients (9.1 versus 4.9 %, p < 0.001).
Conclusions: Within a population of high cost inpatients, the majority of costs are attributed to a single, non-preventable,
acute care episode. However, there are likely opportunities to improve hospital efficiency by focusing on different
approaches to community based care directed towards specific populations.
Keywords: Administrative data, Ambulatory care sensitive conditions, Healthcare cost, Hospitalization
Background
In Canada, total health care expenditures have doubled in
the past decade and are forecasted to exceed $200 billion
by 2014 [1]. While improving patient care and reducing
costs remain a priority within the Canadian health care
system, the fact that actual spending is distributed un-
evenly across individuals in the population creates an
opportunity to direct improvement efforts to a limited
group of patients with a potential high benefit. It has been
estimated that the top 5–10 % of health care users account
for over 50 % of health care utilization and cost [2–6].
Furthermore, approximately 40 % of all health spending is
for hospital care which is similarly skewed towards the so-
called ‘high-user’ [1, 5, 6]. For these reasons, it is logical to
assess hospital spending in this patient population.
While a number of prior studies have characterized
high cost hospital patients [3–12], there are limited data
to direct efforts in a single-payer publicly funded health
* Correspondence: peronksl@ucalgary.ca
1Department of Community Health Sciences, University of Calgary, 3330
Hospital Drive NW, Calgary T2N 4N1, AB, Canada
Full list of author information is available at the end of the article
© 2016 Ronksley et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ronksley et al. BMC Health Services Research  (2016) 16:165 
DOI 10.1186/s12913-016-1418-2
system. Many of these studies have focused on patients
with specific chronic medical conditions, elderly popula-
tions, or certain insurance beneficiaries within the United
States limiting the usefulness and generalizability of their
findings to an entire health system. Furthermore, few
studies have assessed the hospital resources most com-
monly used during high cost encounters; rather they
look at overall costs. This limits our understanding of
how costs are accumulated, the specific resources that
contribute to overall costing estimates, and the propor-
tion of inpatient spending deemed potentially prevent-
able among high cost inpatients. While the latter has
recently been studied by Joynt et al., within an American
Medicare population, it is unclear how these results trans-
late to other settings with different funding models, like
we have in Canada [5].
It is critical to generate an evidence-base on this topic.
Many hospitals and health systems are faced with financial
pressures. To improve care to these high cost patients,
many have called for re-distribution of resources to pro-
vide better disease management [13, 14]. These efforts are
predicated on the assumption that at least some of the
spending on these users is due to poor coordination of
care. Without understanding the subset of patients,
their health concerns and the treatments that are costing
the system disproportionate amounts, then it is unclear
whether these efforts will bear fruit. For this reason, we used
detailed clinical and administrative data to characterize high
cost patients within a Canadian tertiary-care teaching facility
and determine the proportion of acute care spending
deemed potentially preventable.
Methods
Data sources and study population
This was a retrospective observational study using The
Ottawa Hospital Data Warehouse. The Ottawa Hospital
is a tertiary-care teaching facility with two acute-care
campuses containing 1100 beds. It is the largest referral
centre for a population of 1.1 million people. The Data
Warehouse is a relational database containing informa-
tion from several of The Ottawa Hospital’s information
systems including the patient registration system, clinical
data repository, case costing system, and patient abstracts
for multiple encounter types. Within these data sources,
we identified all individuals (regardless of age) with one or
more inpatient hospitalizations between April 1, 2010 and
March 31, 2011. We excluded hospital events with ad-
mission dates that fell outside of the defined timeframe.
However, events with discharge dates that fell outside
of this timeframe were included.
Identification of high cost patients
Direct costs for each inpatient encounter were identified
within the case costing system of the Ottawa Hospital
Data Warehouse. The case costing system links financial,
clinical, and patient activity information stored within infor-
mation systems of the data warehouse to define ‘intermedi-
ate products’ (e.g. nursing time, medications, laboratory
tests, surgical material, etc.). The direct and indirect costs
for each intermediate product used within an encounter
are then summed for each patient. The Ottawa Hospital
employs a standardized case costing methodology de-
veloped by the Ontario Case Costing Initiative [15], and
is based on the Canadian Institute for Health Information
(CIHI) Management Information Systems guidelines and
the Ontario Healthcare Reporting Standards [16]. The
primary purpose of case costing standards is to ensure
comparability across Canadian hospitals. Costs were
summed for patients with multiple hospitalizations dur-
ing the defined time frame. Using the cumulative direct
cost distribution, we then defined patients in the 1st
percentile of total cost as extremely high cost patients and
those in the upper 5th percentile as high cost patients.
Clinical characteristics and resource utilization
We used information from the patient registry file and
hospital abstracts to measure clinical and demographic
characteristics. Using the first (index) hospitalization for
each patient within the study timeframe, we measured
age, sex, marital status, and comorbidity. Hospital discharge
abstracts data were used to determine the number of hos-
pital encounters during the study period and to identify
specific encounter-level characteristics including admission
and discharge date, admission type (elective, newborn,
urgent, emergency, day surgery admits), most responsible
diagnosis, procedure codes, length of stay (acute, alternate
level of care (ALC) and intensive care unit (ICU) days),
and comorbidity defined using the Elixhauser comorbidity
index and derived Elixhauser comorbidity score [17, 18].
Coded inpatient information within the Ottawa Hospital
Data Warehouse employs the same data quality standards
as the CIHI Discharge Abstracts Database [19] and is
based on the International Statistical Classification of
Diseases and Related Health Problems, 10th revision –
Canada (ICD-10-CA).
In-hospital resource utilization was captured using individ-
ual direct cost details within the case costing system. These
include 11 resource-specific categories based on Ontario
Quality Based Procedures Groupings (e.g. Nursing costs, la-
boratory costs, pharmacy costs, operating room costs
(Additional file 1)). The relative proportion of total cost at-
tributable to each resource category were measured by sum-
ming category costs and dividing them by the total direct
hospital costs for high cost and extremely high cost groups.
Identification of preventable acute care spending
Preventable acute care spending was measured in two
different ways. First, we used the Canadian Institute for
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Health Information ambulatory care sensitive condition
(ACSC) indicator algorithm to identify potentially pre-
ventable hospitalizations. This algorithm defines poten-
tially preventable hospitalizations as those related to
health conditions for which good outpatient care can
likely prevent the need for hospitalization [20]. The use
of the ACSC indicator has been recognized internation-
ally as a measure of adequacy of ambulatory and primary
health care performance [21–23]. Within Canada, there is
a focus on seven conditions: hypertension, diabetes, angina,
asthma, chronic obstructive pulmonary disease (COPD),
epilepsy, and heart failure/pulmonary edema derived from
diagnosis and procedure codes identified within the hos-
pital discharge abstracts data (Additional file 2). Second,
we quantified spending attributable to difficulty dischar-
ging patients as measured by alternate level of care (ALC)
status. ALC status refers to patients who no longer need
acute care services but continue to use hospital resources
while they wait to be discharged to a more appropriate set-
ting [24]. Standardized collection of ALC data is available
within hospital discharge abstracts and is used to isolate
acute and non-acute components of a hospital encounter.
Analysis
Patient characteristics were described using proportions,
means (standard deviation (SD)), and medians (inter-quartile
range (IQR)) where appropriate. Measures were compared
between high cost and non-high cost groups using the two
definitions described above. Next, we calculated the number
of hospitalizations (categorized as 1, 2, 3, ≥4 encounters),
median days in hospital (total and acute days), the pro-
portion of patients with an ICU admission, and the me-
dian total ICU days among those with an ICU encounter.
Similarly, the proportion of patients with at least one ALC
day was calculated, and the median total ALC days among
those with an ALC component to their encounter. In-
hospital mortality and proportion with a 30-day all-cause
readmission to hospital were also calculated across high
cost categories. Admission type and the most frequent
most responsible diagnoses were reported for high cost
groups with a single high cost encounter. Concentration
of direct inpatient spending was calculated across high
cost groups and was reported as a percentage of total dir-
ect inpatient spending as well as the average direct cost
per patient. The proportion of total costs incurred within
each hospital resource category and costs attributable to
ALC days was also measured across high cost groups.
We calculated the proportion of patients with a hos-
pital encounter deemed to be potentially preventable
using the ACSC indicator algorithm for high cost (upper
5th percentile) and non-high cost groups. Based on the
algorithm inclusion/exclusion criteria, estimates were calcu-
lated among patients <75 years of age, and excluded those
that died prior to discharge, and newborn admissions.
Overall and condition-specific estimates were reported
across high cost status. Given limitations in sample size,
this analysis was not conducted using the extremely high
cost (upper 1st percentile) cut-point.
Logistic regression was used to identify independent
predictors of ALC status (defined as one or more ALC
days within a hospital encounter) among high cost patients
(upper 5th percentile). Initially, univariate odds ratios (OR)
were calculated for socio-demographic factors, comorbid-
ity, and clinical factors related to the hospital encounter. A
multivariate model was then developed based on signifi-
cant predictors of ALC status and was reduced using
backwards elimination techniques. As the analysis oc-
curred at the encounter level, robust standard errors
were calculated using the Huber-White “sandwich esti-
mator” to account for clustering of hospitalizations at
the patient level [25, 26]. Further analyses were not con-
ducted using the extremely high cost (upper 1st percentile)
cut-point based on sample size limitations. For all statis-
tical tests, p < 0.05 was considered statistically significant.
All analyses were conducted using STATA 13.0 statistical
software (Statacorp, College Station, TX). This study
was approved by the Ottawa Health Sciences Network
Research Ethics Board and granted waiver of patient
consent.
Results
Clinical characteristics and resource utilization among
high cost inpatients
Between April 1, 2010 and March 31, 2011 a total of
36,892 patients had 44,066 hospitalizations. Cumulative
direct costs of ≥ $83,000 and ≥ $33,000 defined the upper
1 and 5 percentiles respectively. Based on these cost cut-
points, 369 patients constituted the extremely high cost
group and 1844 patients the high cost group. In general,
both high cost groups were older, more likely to be male,
and had higher levels of comorbidity compared to their
non-high cost comparators (Table 1). In particular,
hypertension (uncomplicated), diabetes (with or without
complications), cardiac arrhythmias, cancer, congestive
heart failure, and COPD were the most prevalent condi-
tions amongst high cost patients.
High cost groups were more likely to have multiple
hospital encounters compared to non-high cost patients
(Table 2). However, over half of the high cost patients
accumulated costs from a single event (top 1; 52.3 % and
top 5; 54.3 %). Median total days spent in hospital were
markedly higher for high cost patients compared to non-
high cost patients (52 days versus 3 days). The proportion
of high cost patients with at least one ICU admission was
also larger than the non-high cost comparator (48.4 versus
7.1 %) and high cost patients were more likely to have
ALC days during their hospital encounter (33.2 versus
2.7 %). These values increased for those that were in the
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Table 1 Patient characteristics
Top 1 % Top 5 %
Variable All High Cost Non High Cost High Cost Non High Cost
(n = 36,892) (n = 369) (n = 36,523) (n = 1,844) (n = 35,048)
Age, yrs median (IQR) 46 (26–68) 61 (47–74) 45 (26–68) 66 (52–78) 44 (25–67)
Category, %
- 0–18 18.9 7.9 19.0 6.0 19.5
- 19–45 31.2 15.7 31.3 12.0 32.2
- 46–69 27.0 45.5 26.8 39.6 26.3
- 70–79 11.4 17.3 11.3 21.3 10.9
- 80+ 11.6 13.6 11.6 21.1 11.2
Male, % 39.5 57.5 39.3 54.4 38.7
Marital Status, %
- Married/Common-law 51.3 49.3 51.3 53.1 51.2
- Single 31.5 29.8 31.5 22.2 31.9
- Separated/Divorced/Widowed 12.9 17.9 12.9 22.1 12.5
- Unknown 4.3 3.0 4.3 2.6 4.4
Elixhauser Comorbidities, %
- Congestive heart failure 3.8 12.7 3.7 10.5 3.5
- Cardiac arrhythmias 5.6 15.7 5.5 14.9 5.1
- Valvular disease 1.0 1.6 1.0 1.8 0.9
- Pulmonary circulation disorders 1.0 4.3 1.0 3.2 0.9
- Peripheral vascular disorders 3.0 7.1 3.0 8.7 2.7
- Hypertension (uncomplicated) 12.2 23.9 12.1 29.7 11.3
- Hypertension (with complications) 0.3 1.6 0.3 1.1 0.3
- Paralysis 1.1 7.9 1.1 5.3 0.9
- Neurodegenerative disorders 3.2 8.7 3.2 8.6 3.0
- COPD 5.4 12.2 5.3 11.7 5.1
- Diabetes (uncomplicated) 8.6 15.5 8.5 16.8 8.2
- Diabetes (with complications) 7.7 23.6 7.5 21.8 6.9
- Hypothyroidism 1.3 2.2 1.3 2.3 1.2
- Renal failure 2.9 6.8 2.9 8.1 2.7
- Liver disease 1.4 4.9 1.3 3.9 1.2
- Peptic ulcer disease, no bleeding 0.6 3.0 0.5 1.6 0.5
- AIDS/HIV 0.2 0.3 0.2 0.5 0.2
- Lymphoma 1.2 4.3 1.2 4.4 1.1
- Metastatic cancer 4.4 4.9 4.4 7.2 4.3
- Solid tumor without metastasis 11.2 14.1 11.2 18.9 10.8
- Rheumatoid arthritis 0.9 1.9 0.9 1.6 0.8
- Coagulopathy 1.2 5.2 1.2 3.9 1.1
- Obesity 1.6 2.7 1.5 2.1 1.5
- Fluid and electrolyte disorders 1.2 4.1 1.2 4.3 1.1
- Blood loss anemia 0.2 0.5 0.2 0.4 0.2
- Deficiency anemia 1.2 2.7 1.2 3.0 1.1
- Alcohol abuse 2.0 6.2 1.9 4.1 1.8
- Drug abuse 1.1 2.7 1.1 2.0 1.1
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top 1 % high cost group with almost three-quarters
(73.4 %) having at least one ICU day and 37.1 % spending
one or more hospital days in an ALC setting. Finally, in-
hospital mortality and 30-day all-cause readmission were
higher in the high cost cohorts. Approximately 20 % of
high cost patients died in hospital and over 30 % were
readmitted. These proportions were higher for the ex-
tremely high cost cohort.
Given the large proportion of high cost patients that
accumulated cost from a single encounter, admission
type and most responsible diagnosis for these events
were explored (Additional file 3). Approximately 60 %
of extremely high cost patients with a single
hospitalization (n = 193) were emergency admissions.
The most frequent diagnoses for these patients were
acute respiratory failure, sepsis, or low birth-weight
delivery with average length of stays often exceeding
60 days. Similar findings were observed in high cost
patients in the top 5 % percentile with a single en-
counter (n = 1002).
Acute care spending
Approximately $320 million in direct inpatient spending
was accumulated over the study period (Table 3). The
top 1 and 5 % of patients accounted for 15.3 and 38.1 %
of total spending. The average (SD) cost per patient was
$8,716 (17,646). This was markedly higher for those in
the top 1 and 5 % ($133,190 (57,739) and $66,407
(44,326) respectively). Nursing costs accounted for al-
most half of the total spending within the entire study
cohort (45.7 %). While nursing costs remained a large
component of total spending within high cost groups, over
one third (34 %) of expenditures among extremely high
cost patients were related to special care unit resources
(ICU care). High cost groups also had higher proportional
spending on pharmacy and health professional services.
Preventable acute care spending
Among all inpatients aged <75 years, the proportion of
patients with a hospital encounter deemed ambulatory
care sensitive was 2.9 % (95 % CI: 2.7–3.2) (Table 4).
Table 1 Patient characteristics (Continued)
- Psychosis 0.9 1.4 0.9 1.7 0.9
- Depression 2.2 5.4 2.1 3.8 2.1
Elixhauser Comorbidity Score, median (IQR) 0 (0–4) 4 (0–11) 0 (0–4) 5 (0–11) 0 (0–4)
Data Source: Ottawa Hospital Data Warehouse
Abbreviations: AIDS/HIV Acquired Immune Deficiency Syndrome/Human Immunodeficiency Virus, COPD Chronic Obstructive Pulmonary Disease, IQR Inter-quartile Range
Table 2 Number of hospitalizations and length of stay among high cost inpatients
Top 1 % Top 5 %
Variable All High Cost Non High Cost High Cost Non High Cost
(n = 36,892) (n = 369) (n = 36,523) (n = 1,844) (n = 35,048)
Number of hospitalizations, %
1 86.5 52.3 86.9 54.3 88.2
2 9.9 19.5 9.8 22.6 9.2
3 2.3 12.2 2.2 11.8 1.8
≥ 4 1.3 16.0 1.1 11.3 0.8
Total days in hospital, median (IQR) 3 (2–7) 91 (62–129) 3 (2–7) 52 (35–77) 3 (2–6)
Acute days in hospital, median (IQR) 3 (2–7) 68 (48–99) 3 (2–7) 40 (27–58) 3 (2–6)
≥1 ALC day, % 4.2 37.1 3.9 33.2 2.7
ALC days in hospital, median (IQR)a 13 (5–34) 43 (17–126) 12 (5–30) 31 (11–68) 8 (4–20)
≥1 ICU admission, % 9.2 73.4 8.6 48.4 7.1
ICU days in hospital, median (IQR)b 4 (1–10) 26 (14–39) 3 (1–9) 14 (8–25) 2 (1–6)
In-hospital mortality, % 4.6 21.7 4.4 20.4 3.8
30-day all-cause readmission, %c (n = 35,067) 6.8 (n = 310) 35.8 (n = 34,757) 6.5 (n = 1548) 31.9 (n = 33,519) 5.6
Data Source: Ottawa Hospital Data Warehouse
Note: Total length of stay is Acute days + ALC days. Acute days include ICU days
Abbreviations: ALC Alternate Level of Care, ICU Intensive Care Unit, IQR Inter-quartile Range
aAmong patients with at least 1 ALC day
bAmong patients with an ICU admission
cAmong patients eligible for hospital readmission (excludes patients that died in hospital prior to discharge)
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This was twice as high for high cost patients relative to
non-high cost patients (6.0 %; 95 % CI: 4.5–7.5 versus
2.8 %; 95 % CI: 2.6–3.0) (χ2 p < 0.001). While the absolute
values are small, the most common condition-specific
ACS hospitalizations related to COPD, CHF/Pulmonary
edema, and diabetes. These proportions were consistently
higher among the high cost cohort relative to their
non-high cost comparator.
Approximately 9 % of total direct inpatient spending
among high cost patients was attributable to ALC days
(Table 3). This value was significantly higher than the
proportion of spending attributed to ALC days within
non-high cost comparators (4.9 %) (χ2 p < 0.001). Based
on our regression analysis, the odds of having one or
more ALC days among high cost inpatients increased
with age (Fig. 1). Patients 80 years of age or older were
seven times more likely to have ALC days compared to
patients ≤45 years of age (OR: 7.72; 95 % CI: 5.09–11.72).
The odds of having ALC days were higher for single pa-
tients, widowed/divorced or separated patients (com-
pared to married patients), and those with neurological
comorbidity, while high cost patients with cancer-related
Table 3 Concentration of direct inpatient spending and resource utilization among high cost patients
All Top 1 % Top 5 %
(n = 36,892) (n = 369) (n = 1844)
Direct Inpatient Spending ($) 321,556,160 49,147,104 122,454,872
Percentage of total inpatient spending (%) 100.0 15.3 38.1
Average direct cost per patient $ (SD) 8,716 (17,646) 133,190 (57,739) 66,407 (44,326)
Resource Utilization (proportion of direct inpatient spending) %
Endoscopy 0.3 0.3 0.3
Food Services 2.5 2.3 2.6
Health Professionals 5.0 9.4 7.7
Imaging 3.2 2.8 3.2
Laboratory 7.2 4.9 5.5
Nursing 45.7 33.7 40.2
Operating Room 8.7 2.0 3.1
Operating Room Implants 4.2 1.5 2.0
Pharmacy 6.7 8.7 8.4
Post-anesthesia Care Unit 2.1 0.4 0.7
Special Care Unit 14.4 34.0 26.3
Direct inpatient spending attributable to ALC days $(%) $15,789,200 (4.9 %) $3,985,800 (8.1 %) $11,140,500 (9.1 %)
Data Source: Case Costing System within Ottawa Hospital Data Warehouse
Abbreviations: ALC Alternate Level of Care, SD Standard Deviation
Table 4 Proportion of patients with an ambulatory care sensitive hospital encounter
All patients High Cost (Top 5 %) Non-High Cost (Lower 95 %)
(n = 23,620) (n = 968) (n = 22,652)
N % (95 % CI) N % (95 % CI) N % (95 % CI)
Any ACSC Hospitalization 695 2.9 (2.7–3.2) 58 6.0 (4.5–7.5) 637 2.8 (2.6–3.0)
Condition-specific Hospitalization
- Epilepsy 78 0.3 (0.2–0.4) 7 0.7 (0.2–1.3) 71 0.3 (0.2–0.4)
- COPD 266 1.1 (0.9–1.3) 23 2.4 (1.4–3.3) 243 1.1 (0.9–1.2)
- Asthma 47 0.2 (0.1–0.3) 2 0.2 (0.0–0.5) 45 0.2 (0.1–0.3)
- CHF/Pulmonary Edema 135 0.6 (0.5–0.7) 12 1.3 (0.5–2.0) 123 0.6 (0.4–0.7)
- Hypertension 13 0.1 (0.0–0.1) 0 0 (0–0) 13 0.1 (0.0–0.1)
- Angina 37 0.2 (0.1–0.3) 1 0.1 (0.0–0.3) 36 0.2 (0.1–0.3)
- Diabetes 112 0.5 (0.4–0.6) 13 1.3 (0.6–2.1) 99 0.4 (0.3–0.5)
Data Source: Ottawa Hospital Data Warehouse
Abbreviations: ACSC Ambulatory Care Sensitive Condition, CHF Congestive Heart Failure, CI Confidence Interval
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comorbidities were less likely. Furthermore, patients with
emergency admissions were two times more likely to have
ALC days compared to those with elective admissions
(OR: 2.47; 95 % CI: 1.72–3.56).
Discussion
In this cohort of patients from a Canadian academic
acute care centre, we found that a small proportion of
patients accounted for the majority of hospital spending.
While the clinical characteristics of these patients varied
substantially, high cost patients were often elderly, med-
ically complex, and accumulated high costs from a single
hospital encounter. These costs were generated predom-
inantly from nursing care and from special units such as
intensive care. This suggests a limit in the ability to re-
duce this spending, as it appears that these patients are
simply very sick and therefore require expensive care.
On the other hand, the proportion of acute care spend-
ing deemed potentially preventable amongst this high-
risk group was not inconsequential. Almost 50 % of
these patients had multiple admissions (many represent-
ing readmissions), 6 % of them had an encounter that
was deemed ambulatory care sensitive, and almost 10 %
of total direct inpatient spending was attributable to dif-
ficulties transitioning high cost patients to alternate care
settings. While these appear to be areas to focus, there
would of course be offsetting costs for providing care
elsewhere.
Our findings suggest some opportunities for improved
value for money but should also be viewed cautiously. It
is clear that in a hospital setting there is significant con-
centration of spending within a small group of patients,
who on the whole were older and sicker than all other
patients. What is not entirely clear is whether we can
use this information to guide improvements in services
or whether other avenues of potentially preventable in-
patient spending should be considered (e.g. patient safety
indicators such as adverse events in hospital). We did find
several patterns suggesting a direction for improvement.
The most important finding, in our view, is that over a
Fig. 1 Predictors of one or more ALC days among high cost inpatients
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third of high cost patients had at least one ALC day and
that spending on this level of care attributed to almost
10 % of the overall spending in this group. It is likely that
difficulty finding discharge locations is the cause of the
spending, as these values are higher than those observed
in our overall population, which are comparable to the
general Canadian population, ranging from 2–7 % [24]. It
is also likely that there are diverse sets of inter-related so-
cial and medical factors contributing to this situation that
would require additional exploration through a mixed-
methods approach. Regardless of cause, this is not ac-
ceptable in an academic hospital that is supposed to be
reserved for providing the most complex advanced ter-
tiary care. Importantly, we were able to identify specific
patient characteristics that increased the likelihood of
incurring ALC day among the most costly inpatients in-
cluding increased age, marital status and specific comor-
bid conditions. Improving transitions of care for those at
greatest risk of having ALC days may therefore represent
an avenue where costs could be contained. However, this
relies on the need for improved models of community-
based care for complex medical patients and an explor-
ation of the potential barriers that impede efficient transi-
tions out of acute care [27]. Whether the costs associated
with these alternative approaches are less than what is
spent in hospital remains to be determined.
Similar to other investigators, we also found that there
were significant admissions for so-called ambulatory care
sensitive conditions. Joynt et al. recently quantified pre-
ventable acute care spending among high cost Medicare
beneficiaries and found that 15.8 % of hospitalizations
were attributable to preventable causes [5]. This rate is
almost three times higher than we observed. This opens
up the possibility that our publicly funded system, pro-
viding universal access to primary care, may have signifi-
cant downstream benefits. In contrast, while Joynt and
colleagues did not explicitly report on costs attributable
to difficulty discharging patients, ALC-related spending
may simply be a Canadian health system phenomenon.
There is therefore a need for comparative research across
health care models and a determination of system factors
that may create inefficiencies in acute care spending at ei-
ther end of the hospital encounter. Similar to our results,
they found that COPD and CHF were two of the most
common diagnoses for preventable hospitalizations. Im-
proving outpatient management for patients with chronic
disease remains a priority within health care. Various out-
patient interventions have been shown to reduce the risk
of re-hospitalization, and in turn inpatient costs, in the
setting of specific chronic conditions; most notably COPD
[28–30]. Whether these interventions can be put in place
to reduce ACS hospitalizations for medically complex pa-
tients, with multiple comorbidities, remains to be deter-
mined and represents an area of future research. Despite
this, it is important to interpret these findings in absolute
terms. The fact that only 6 % of hospital encounters were
deemed ambulatory care sensitive suggests it may be diffi-
cult to target specific sub-groups of high cost, medically
complex patients to intervene upon.
Our study has a number of strengths, including a large
sample of all patients referred to a typical acute care
hospital within Canada. The use of detailed clinical and
costing information also provides us with valuable insight
into the characteristics of high cost patients and the spe-
cific hospital resources they use. However, our study
should also be interpreted in light of its limitations. First,
we did not assess spending outside of the hospital setting.
While inpatient spending makes up a large proportion of
health care spending, there is likely a number of different
“high cost” profiles based on spending outside of the acute
care setting. Specifically, our estimated costs do not in-
clude physician expenditures, which would result in an
underestimate of total spending. However, the relative
contribution of physician costs to the total expenditures is
fairly small among high system users [31]. Second, our in-
clusion criterion was limited to admissions that occurred
within one fiscal year resulting in potential misclassifica-
tion of high cost patients based on differential follow-up
times. In this specific scenario, it is likely to underestimate
the total number of high cost patients identified but have
minimal impact on the overall study findings including
the varied clinical profiles of high cost patients and that
these costs were often attributed to a single hospital en-
counter. Third, our estimates of preventable hospitaliza-
tions using the ACS algorithm should be interpreted with
caution as they exclude a proportion of patients identified
as high cost based on our operational definition (i.e.
newborns and patients >75 years). This may underesti-
mate the total proportion of events deemed potentially
avoidable. Our estimates also represent a spectrum of
preventability that requires exploration into other as-
pects of patient care, including supply and use of out-
patient services. It also requires the inclusion of system/
provider-level metrics of primary care performance in the
analysis of ACS hospitalization as well as additional
patient-level factors related to chronic disease progression
or severity. Finally, this study was limited to a single
Canadian tertiary care setting and may not be generalizable
to other jurisdictions with variations in primary care
delivery, capacity to care for patients within the com-
munity, and patient characteristics. While the majority
of residents of Ottawa and surrounding areas are served
by the 2 acute care facilities included within our ana-
lysis, there are other inpatient facilities that are not
captured within the Ottawa Hospital Data Warehouse.
Although it is possible that a proportion of high and
non-high users may be misclassified based on inpatient
use within and outside of those reported to the Data
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Warehouse, we believe this is likely to be non-differential
in nature.
Conclusions
In summary, within a population of high cost inpatients,
we found that an important proportion of costs appear
to be related to preventable hospital days – resulting
from ambulatory care sensitive and repeat encounters and
more importantly difficulty discharging patients. While
improving care and mitigating costs remain paramount,
these results suggest there are opportunities to lower costs
for these patients through better outpatient management
and coordination of care. Future work is needed to ex-
plore the potential barriers impeding efficient transitions
out of acute care for complex medical patients. There is
also a need to develop population-based estimates on
preventable acute care spending and to explore how
variations in coordination of care and care delivery models
influence these estimates.
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